XML 16 R6.htm IDEA: XBRL DOCUMENT v3.24.0.1
Condensed Consolidated Statements of Stockholders’ Equity - USD ($)
$ in Thousands
Total
Rights Offering
Private Placement
Series A Preferred Stock
Common Stock
Common Stock
Rights Offering
Common Stock
Private Placement
Treasury Stock
Additional Paid-in Capital
Additional Paid-in Capital
Rights Offering
Additional Paid-in Capital
Private Placement
Accumulated Other Comprehensive Loss
Accumulated Deficit
Shares outstanding at beginning of period (in shares) at Dec. 31, 2021       0 42,296,121                
Stockholders' equity at beginning of period at Dec. 31, 2021 $ 422,491       $ 4     $ (4,445) $ 586,349     $ (3,725) $ (155,692)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Shares issued in connection with options exercise, net exercised (in shares)         495,052                
Shares issued in connection with options exercise, net exercised 1,925               1,925        
Shares issued in connection with equity incentive plans (in shares)         2,506,860                
Shares issued pursuant to a license, services and collaboration agreement (in shares)         27,599                
Shares issued in connection with asset purchase (in shares)         103,570                
Shares issued in connection with asset purchase 1,333               1,333        
Shares issued in connection with preferred shares agreement (in shares)       50,000                  
Shares issued in connection with the settlement of the performance holdback contingent consideration relating to the acquisition of GlowUp (in shares)         352,923                
Shares issued in connection with the settlement of the performance holdback contingent consideration relating to the acquisition of GlowUp 260               260        
Stock-based compensation expense and vesting of restricted stock units 17,141               17,141        
Other comprehensive income (loss) (25,040)                     (25,040)  
Net loss (267,469)                       (267,469)
Shares outstanding at end of period (in shares) at Sep. 30, 2022       50,000 45,782,125                
Total stockholders' equity at end of period at Sep. 30, 2022 150,641       $ 4     (4,445) 607,008     (28,765) (423,161)
Shares outstanding at beginning of period (in shares) at Jun. 30, 2022       25,000 45,621,763                
Stockholders' equity at beginning of period at Jun. 30, 2022 419,888       $ 4     (4,445) 601,237     (18,444) (158,464)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Shares issued in connection with options exercise, net exercised (in shares)         142,021                
Shares issued in connection with options exercise, net exercised 476               476        
Shares issued in connection with equity incentive plans (in shares)         15,029                
Shares issued pursuant to a license, services and collaboration agreement (in shares)         3,312                
Shares issued in connection with preferred shares agreement (in shares)       25,000                  
Stock-based compensation expense and vesting of restricted stock units 5,295               5,295        
Other comprehensive income (loss) (10,321)                     (10,321)  
Net loss (264,697)                       (264,697)
Shares outstanding at end of period (in shares) at Sep. 30, 2022       50,000 45,782,125                
Total stockholders' equity at end of period at Sep. 30, 2022 150,641       $ 4     (4,445) 607,008     (28,765) (423,161)
Shares outstanding at beginning of period (in shares) at Dec. 31, 2022       50,000 47,037,699                
Stockholders' equity at beginning of period at Dec. 31, 2022 155,252       $ 5     (4,445) 617,233     (24,145) (433,396)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Issuance of common stock (in shares)           19,561,050 6,357,341            
Issuance of common stock   $ 47,602 $ 13,890     $ 2       $ 47,600 $ 13,890    
Exchange of mandatorily redeemable preferred shares (in shares)       (50,000)                  
Shares issued in connection with equity incentive plans (in shares)         944,002                
Shares issued pursuant to a license, services and collaboration agreement (in shares)         3,312                
Shares issued in connection with asset purchase 0                        
Stock-based compensation expense and vesting of restricted stock units 10,857               10,857        
Other comprehensive income (loss) (3,150)                     (3,150)  
Net loss (176,660)                       (176,660)
Shares outstanding at end of period (in shares) at Sep. 30, 2023       0 73,903,404                
Total stockholders' equity at end of period at Sep. 30, 2023 47,791       $ 7     (4,445) 689,580     (27,295) (610,056)
Shares outstanding at beginning of period (in shares) at Jun. 30, 2023       0 73,797,250                
Stockholders' equity at beginning of period at Jun. 30, 2023 54,838       $ 7     (4,445) 688,280     (26,113) (602,891)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Shares issued in connection with equity incentive plans (in shares)         106,154                
Stock-based compensation expense and vesting of restricted stock units 1,300               1,300        
Other comprehensive income (loss) (1,182)                     (1,182)  
Net loss (7,165)                       (7,165)
Shares outstanding at end of period (in shares) at Sep. 30, 2023       0 73,903,404                
Total stockholders' equity at end of period at Sep. 30, 2023 $ 47,791       $ 7     $ (4,445) $ 689,580     $ (27,295) $ (610,056)